Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine

Published:2021-02-01 Issue:2 Volume:181 Page:284
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

McCormick Natalie¹,Wallace Zachary S.¹,Yokose Chio¹,Jorge April¹,Sacks Chana A.²,Hsu John³,Choi Hyon K.¹

Affiliation:

1. Clinical Epidemiology Program,Division of Rheumatology, Allergy, and Immunology,Massachusetts General Hospital, Harvard Medical School, Boston

2. Division of General Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston

3. Department of Health Care Policy, Massachusetts General Hospital, Harvard Medical School, Boston

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2773233/jamainternal_mccormick_2020_ld_200061_1611344071.78888.pdf

Reference6 articles.

1. Efficacy and safety of low-dose colchicine after myocardial infarction.;Tardif;N Engl J Med,2019

2. The colchicine debacle.;Guglielmo;JAMA Intern Med,2013

3. Analysis of proposed Medicare Part B to Part D shift with associated changes in total spending and patient cost-sharing for prescription drugs.;Hwang;JAMA Intern Med,2019

4. Reductions in use of colchicine after FDA enforcement of market exclusivity in a commercially insured population.;Kesselheim;J Gen Intern Med,2015

5. Effect of generic competition on atorvastatin prescribing and patients’ out-of-pocket spending.;Luo;JAMA Intern Med,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands;European Heart Journal - Quality of Care and Clinical Outcomes;2024-03-14

2. Update on the Role of Colchicine in Cardiovascular Disease;Current Cardiology Reports;2024-02-10

3. Industry‐sponsored meal payments are associated with prescriptions and Medicare expenditures on brand‐name colchicine in the United States;International Journal of Rheumatic Diseases;2023-11-03

4. Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease;European Journal of Preventive Cardiology;2023-07-06

5. Changes in Prescription Drug and Health Care Use Over 9 Years After the Large Drug Price Increase for Colchicine;JAMA Internal Medicine;2023-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3